Volker H. Haase

机构：Vanderbilt University, VA Tennessee Valley Healthcare System, Tennessee Oncology, Nashville Oncology Associates, Vanderbilt University Medical Center · ORCID：0000-0002-7051-8994

发表论文 173 篇 · 总被引 19503 次 · h-index 67

代表论文

• Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference (2023 · Kidney International · 被引 141)
• EPO synthesis induced by HIF‐PHD inhibition is dependent on myofibroblast transdifferentiation and colocalizes with non‐injured nephron segments in murine kidney fibrosis (2022 · Acta Physiologica · 被引 37)
• KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD) (2026 · Kidney International · 被引 35)
• Updates on Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in the Treatment of Renal Anemia (2022 · Kidney Diseases · 被引 35)
• Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease (2022 · American Journal of Hematology · 被引 23)
• Lipid kinase PIK3C3 maintains healthy brown and white adipose tissues to prevent metabolic diseases (2022 · Proceedings of the National Academy of Sciences · 被引 22)